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Abstract 
We have previously shown that neopterin, 6-o-erythro-trihydroxypropyl-pteridine, synthesized by human monocytes/macrophages upon stimula- 
tlon by interferon-y, enhances toxicity of reactive oxygen at neutral or slightly alkaline pH (7.5), but not at acidic pH (below 6.5). In the present 
study, we explored in more detail the necessary requirements for neopterin to modulate the effects of hydrogen peroxide in a luminol-dependent 
chemiluminescence assay. We demonstrate that neopterin enhances hydrogen peroxide effects only in the presence of iron chelator complexes like 
iron-(III)- or iron-(II)-EDTA or iron-(III)-DTPA. Thus, iron chelator complexes together with neopterin may play an important role in macrophage- 
mediated effector mechanisms. 
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1. Introduction 
Activated macrophages produce, besides a lot of other 
secretory products, reactive metabolites of oxygen such 
as hydrogen peroxide, superoxide, hydroxyl radicals and 
possibly singlet oxygen [l]. Hydrogen peroxide is a cen- 
tral molecule in mediating macrophage-mediated ex- 
tracellular cytolysis [2]. Upon stimulation by interferon- 
y, macrophages produce and release large amounts of 
neopterin [3], which is synthesized from guanosine tri- 
phosphate (GTP); GTP is converted by GTP-cyclohy- 
drolase I (EC 3.5.4.16) to 7,8_dihydroneopterin tri- 
phosphate. Because human macrophages in contrast to 
a variety of other cells have only a very low activity of 
6-pyruvoyl tetrahydropterin synthase, the second en- 
zyme in tetrahydrobiopterin biosynthesis, 7,8-dihydro- 
neopterin triphosphate accumulates and is cleaved by 
phosphatases to 7,8_dihydroneopterin [4], which is then 
partly oxidized to neopterin. Elevations of neopterin 
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have been found in viral infections, various malignant 
disorders, autoimmune diseases and during allograft re- 
jection episodes [5-l 11. From these studies neopterin has 
turned out to be a useful marker for monitoring of acti- 
vation of cellular immunity in patients, but so far no 
biological role of neopterin has been clarified. 
However, Heales et al. [12] showed that 7,8-dihy- 
droneopterin scavenges luminol-dependent chemilumi- 
nescence of zymosan-activated human macrophages, 
and Kojima et al. [13] found a scavenging activity by 
neopterin on superoxide radical anion. On the other 
hand, we demonstrated [14] that neopterin enhances hy- 
drogen peroxide and chloramine T activity in a luminol- 
dependent chemiluminescence assay and also strenght- 
ens toxicity of these agents against bacteria at slightly 
alkaline pH (pH 7.9, while 7,8_dihydroneopterin was 
shown to be a scavenger independently from pH value. 
Finally Kojima et al. [ 151 reported a suppression of su- 
peroxide-generating NADPH-oxidase by neopterin 
using macrophages timulated with phorbol myristate 
acetate. In order to clarify these seemingly contradictory 
findings about the interaction between neopterin and 
activated oxygen species, we investigated in more detail 
which requirements govern the influence of neopterin on 
hydrogen peroxide-induced luminol-dependent chemilu- 
minescence. 
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2. Materials and methods 
2. I, Reagents 
Dulbecco’s phosphate-buffered saline (PBS) was purchased from 
Serva Co., Ltd. (Heidelberg, Germany) and Sigma Chemicals Co., Ltd. 
(St. Louis, MO), phosphate-buffered saline from BioMCrieux (Marcy 
I’Etoile, France). Disodium hydrogen phosphate, potassium dihydro- 
gen phosphate, sodium chloride, potassium chloride, dimethyl sulfox- 
ide (DMSO), iron-(II)-sulfate, iron-(III)-chloride, ethylenediamine 
tetraacetic acid disodium salt (EDTA), diethylenetriamine p ntaacetic 
acid (DTPA), potassium hexacyanoferrate-(III), tin-(II)-chloride, ba- 
rium chloride and manganese chloride were from Merck (Darmstadt, 
Germany) at the highest purity grade available. Luminol @-amino-2,3- 
dihydro-1,4_phthalazinedione) was also from Sigma. D-Erythro-neop- 
terin was obtained from Dr. B. Schircks laboratories (Jona, Switzer- 
land). 
2.2. Preparation of buffer solutions 
Effects of neopterin were investigated in four solutions from distinct 
manufacturers. Buffer salts from Serva (= solution A), that we have 
been using in previous studies [14], buffer salts from Sigma (= solution 
C) and BioMtrieux (= solution D) were dissolved in distilled water 
according to preparation instructions by the manufacturers, yielding a 
final concentration of 4.2 mM potassium, 153 mM sodium, 140 mM 
chloride, 1.47 mM dihydrogen phosphate and 8.1 mM hydrogen phos- 
phate in solutions A and C, respectively. Additionally a buffer solution 
was prepared with high grade purity reagents from Merck (= solution 
B) in identical final concentrations of ions as mentioned above. Solu- 
tion D was registrated by the manufacturer to contain 150 mM phos- 
phate-buffered saline. If necessary, pH was adjusted to pH 7.5 by 
addition of hydrochlorous acid or sodium hydroxide. 
For further investigations solution B was supplemented with aqueous 
solutions of iron-(II)-sulfate (= solution a), iron-(III)-chloride (= solu- 
tion b), iron-(II)-sulfate and EDTA (= solution c), iron-(III)-chloride 
and EDTA (= solution d), iron-(III)-chloride and DTPA (= solution e), 
and potassium hexacyanoferrate-(III) (= solution f, maintaining an 
iron concentration of 2.3 PM and an EDTA or DTPA concentration 
of 4.6 flM. 
2.3. Luminol-dependent measurement of chemiluminescence 
Neopterin was dissolved in solutions A, B, C or D at pH of 7.5 
yielding a final concentration of 30 PM. Luminol was dissolved in 
DMSO at a concentration of 10 mM and a40pM working solution was 
freshly prepared by dilution with solution A-D or a-f. 120~1 of luminol 
solution and 600 ~1 of solutions A-D and a-f without (= control) and 
with neopterin were incubated for 60 s in microcuvettes at 37°C in a 
luminometer (LKB 1251, Pharmacia, Piscataway, NJ). 140 ~1 of 1% 
hydrogen peroxide (0.29 M) solution were injected and light output was 
measured for 30 s at 37°C. Maximum light output of samples was 
compared to that of controls. 
2.4. Analysis of elements 
Analysis of elements was done by inductively coupled plasma mass 
spectrometry (ICP-MS) on a VG Plasma Quad 2.Turbo Plus (VG 
Elemental Ltd., Winsford, UK), equipped with a Gilson Miniplus- 
peristaltic pump, a Meinhard nebulizer (type TR-30-A3) and a water- 
cooled (5Oc) Scott-type double pass spra; ihamber. 1 ml of each sam- 
ple was diluted with 8.4 ml of distilled water after addition of 500 ~1 
of double distilled nitric acid and 100 ~1 of a 87 PM indium solution 
(supplied by Merck, Darmstadt, Germany). A blank solution was pre- 
pared by dissolving 1.7 mmol sodium chloride in 10 ml of distilled water 
after addition of 500 ~1 of a double distilled nitric acid and 100 ~1 of 
a 87 PM indium solution. Data were quantified with respect o a single 
internal standard (indium) and corrected for mass bias by means of a 
measured mass response curve. For the mass response curve a multi- 
element standard solution containing magnesium, cobalt, indium, lan- 
thanum, lead, bismuth and uranium with a concentration of 100 fig/l 
was measured. To compensate matrix effects this standard solution was 
made with a concentration of 17 mM sodium chloride. According to 
the indium counts found in the sample solutions all concentrations of 
the other elements were calculated with the response curve. From each 
sample the counts of the blank solution mentioned above were sub- 
tracted. 
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Fig. 1. Effect of neopterin on hydrogen peroxide-induced luminol- 
dependent chemiluminescence in different phosphate buffers (A, Serva; 
B, Merck; C, Sigma; D, BioMCrieux) at pH 7.5. Light output after 
addition of hydrogen peroxide (final concentration 53 mM) to luminol 
and the buffer solution was used as control. Peak values of the investi- 
gated samples without (control) and with neopterin are shown. Plots 
show mean values (mean + one standard deviation) in a logarithmic 
scale for two independent experiments each of which was performed in 
duplicate. 
3. Results 
As pointed out in Fig. 1, neopterin enhances hydrogen 
peroxide-induced chemiluminescence about ninefold 
using solution A. In contrast there was no effect of neop- 
terin in solution C, solution B and D showing even a 
slight scavenging effect of neopterin. 
An ICP-MS analysis of the four solutions confirmed 
that these solutions contained certain elements in varying 
concentrations. As seen in Table 1, solution A has a 
higher content of iron, manganese, tin and barium than 
all other solutions. Other differences of elements of solu- 
tions A-D did not appear to be associated with distinct 
results obtained in luminol reaction. 
When we supplemented solution B with iron-(II)-sul- 
fate, iron-(III)-chloride, manganese chloride, tin-(II)- 
chloride or barium chloride alone and in various combi- 
nations, we could not find any striking influence on the 
effect induced by neopterin in hydrogen peroxide- 
induced luminol-dependent chemiluminescence (results 
of iron supplementation are shown in Fig. 2). 
In contrast, when we supplemented solution B with 
iron-(II)-sulfate or iron-(III)-chloride in combination 
with EDTA, neopterin enhanced hydrogen peroxide-in- 
duced chemiluminescence eight- and eleven-fold, respec- 
tively (Fig. 2). In case of supplementation with iron-(III)- 
chloride in combination with DTPA, there was a twelve- 
fold enhancement of the signal. Iron supplementation of 
solution B with potassium hexacyanoferrate-(III) caused 
an immense increase of the signal intensity compared to 
controls without iron, however, addition of neopterin 
resulted in scavenging but not enhancing chemilumines- 
cence. 
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Fig. 2. Effect of neopterin on hydrogen peroxide-induced luminol- 
dependent chemiluminescence of solution B as control and after supple- 
mentation of solution B with iron-(IQ-sulfate (a), iron-(III)-chloride 
(b), iron-(II)-sulfate and EDTA (c), iron-(III)-chloride and EDTA (d), 
iron-(III)-chloride and DTPA (e), and potassium hexacyanoferrate- 
(III) (f). 
4. Discussion 
Our data clearly indicate that enhancement of hydro- 
gen peroxide-induced luminol-dependent chemilumines- 
cence by neqpterin requires an iron chelator complex. In 
preparations of buffer solutions using high purity grade 
reagents (solution B) neopterin did not exhibit any en- 
hancing effect. Similarly, upon supplementation of these 
preparations by iron salts, no effect was observed. Only 
solution A (Serva) was capable of enhancing chemilumi- 
nescence. Therefore we suspected that solution A con- 
tained not only iron but also a certain so far not identi- 
fied chelator. Indeed, supplementing solution B with iron 
ions and a chelating agent resulted in similar effects as 
those observed in solution A. A possible explanation for 
the necessity of an iron chelator could be that especially 
Table 1 
Concentrations in yM of elements in solutions A-D. Semiquantitative 
values obtained from two determinations are shown as means 
- 
Element Solution A Solution B Solution C Solution D 
Mg 1.0 0.9 2.0 1.6 
Al 1.1 3.6 12.8 12.7 
P 5653 6285 4808 3257 
Ca 1.8 9.4 8.2 * 
Fe 2.1 * * * 
Mn 0.8 * 0.02 0.05 
Ni 0.2 0.1 0.4 0.7 
cu 0.2 0.3 0.7 0.6 
Zn 0.5 0.1 0.2 0.5 
Br 108 70 345 300 
Ag 0.006 0.002 0.005 0.009 
Sn 0.05 * * * 
Ba 0.88 0.02 0.01 0.07 
Pb 0.05 0.04 0.03 0.06 
- 
*denotes lower concentrations than the blank value. 
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iron-(III) is poorly soluble in aqueous solution at pH 7.5, 
since hydrated polynuclear iron complexes are formed 
which readily precipitate, and a chelator seems to be 
necessary to keep iron ions in dissolved form. The pres- 
ence of one aquo coordination site, remaining after com- 
plex formation, is necessary for the ability of chelated 
iron to catalyze the formation of hydroxyl radicals by the 
Haber-Weiss reaction [ 16,171. However, it is obviously 
not essential for the enhancement of hydrogen peroxide- 
induced luminol-dependent chemiluminescence by neop- 
terin, since EDTA (pentadentate ligand) and DTPA 
(hexadentate ligand) show essentially the same effects. 
Our data may provide an additional explanation of the 
contradictory observations in literature about the inter- 
action of neopterin and reactive oxygen species: On the 
one hand, neopterin enhances toxicity by reactive oxygen 
species only at neutral or slightly alkaline pH (7.5) but 
not at acidic pH (below 6.5) as described earlier [14]. On 
the other hand, the presence of certain iron chelator 
complexes eems to be necessary for the enhancement of 
hydrogen peroxide toxicity by neopterin and may there- 
fore play an important role in macrophage-mediated f- 
fector mechanisms. In contrast to this observations, in 
chloramine T-induced luminol-dependent chemilumines- 
cence the enhancement by neopterin was independent 
from the presence of iron chelator complexes. Using 
chloramine T we observed that neopterin enhanced sig- 
nal strength not only in buffer solution A, but also in 
solution B, where neopterin was unable to enhance hy- 
drogen peroxide-mediated reaction. The scavenging ef- 
fect of 7,8_dihydroneopterin in hydrogen peroxide-in- 
duced luminol-dependent chemiluminescence did not de- 
pend on pH value and the presence of iron chelator 
complexes (unpublished observations). 
Further investigations of the mechanism of enhance- 
ment of hydrogen peroxide-induced chemiluminescence 
by neopterin and the role of biologically important 
chelators of iron are currently under way. 
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